QT
ALXN

Quantamental Technologies’s Alexion Pharmaceuticals ALXN Stock Holding History

Quantamental Technologies’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,753
Closed -$873K – 415
2021
Q2 		$873K Buy
4,753
+1,648
+53% +$283K 0.77% 36
2021
Q1 		$475K Buy
3,105
+1,154
+59% +$179K 1.52% 20
2020
Q4 		$305K Buy
+1,951
New +$251K 0.95% 39
2020
Q1 		– Sell
-4,683
Closed -$506K – 450
2019
Q4 		$506K Sell
4,683
-4,966
-51% -$531K 0.26% 119
2019
Q3 		$945K Buy
9,649
+5,637
+141% +$635K 0.31% 50
2019
Q2 		$525K Buy
4,012
+2,175
+118% +$280K 0.19% 127
2019
Q1 		$248K Sell
1,837
-4,851
-73% -$603K 0.11% 300
2018
Q4 		$651K Buy
+6,688
New +$791K 0.39% 13

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Quantamental Technologies's ALXN Position: Q3 2021 in Review

Quantamental Technologies sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 4,753 shares — an estimated $873K sold.

Quantamental Technologies first reported a position in ALXN in Q4 2018 and held it in 8 quarters. The position peaked at $945K in Q3 2019. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Quantamental Technologies reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Quantamental Technologies sold 4,753 Alexion Pharmaceuticals shares in Q3 2021, an estimated $873K.
  • Quantamental Technologies first reported a position in Alexion Pharmaceuticals in Q4 2018 and held it in 8 quarters.
  • Quantamental Technologies's Alexion Pharmaceuticals position peaked at $945K in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Quantamental Technologies's 13F filing for Q3 2021, filed 15 Nov 2021.